Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of 292.03 billion. The enterprise value is 303.54 billion.

Market Cap	292.03B
Enterprise Value	303.54B

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	3.36B
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.18B

Valuation Ratios

The trailing PE ratio is 19.27 and the forward PE ratio is 16.54.

PE Ratio	19.27
Forward PE	16.54
PS Ratio	6.65
PB Ratio	14.55
P/TBV Ratio	69.12
P/FCF Ratio	25.47
P/OCF Ratio	15.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.99, with an EV/FCF ratio of 26.47.

EV / Earnings	20.03
EV / Sales	6.72
EV / EBITDA	12.99
EV / EBIT	13.87
EV / FCF	26.47

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio	0.74
Quick Ratio	0.54
Debt / Equity	0.86
Debt / EBITDA	0.76
Debt / FCF	1.50
Interest Coverage	41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE)	88.12%
Return on Assets (ROA)	23.29%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	58.02%
Revenue Per Employee	567,426
Profits Per Employee	195,821
Employee Count	77,349
Asset Turnover	0.77
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.02% in the last 52 weeks. The beta is 0.21, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-48.02%
50-Day Moving Average	70.33
200-Day Moving Average	99.50
Relative Strength Index (RSI)	51.32
Average Volume (20 Days)	197,727

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of 43.92 billion and earned 15.16 billion in profits. Earnings per share was 3.40.

Revenue	43.92B
Gross Profit	37.18B
Operating Income	21.27B
Pretax Income	19.17B
Net Income	15.16B
EBITDA	22.50B
EBIT	21.27B
Earnings Per Share (EPS)	3.40

Full Income Statement

Balance Sheet

The company has 6.02 billion in cash and 17.20 billion in debt, giving a net cash position of -11.18 billion.

Cash & Cash Equivalents	6.02B
Total Debt	17.20B
Net Cash	-11.18B
Net Cash Per Share	n/a
Equity (Book Value)	20.07B
Book Value Per Share	4.52
Working Capital	-8.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.02 billion and capital expenditures -7.55 billion, giving a free cash flow of 11.47 billion.

Operating Cash Flow	19.02B
Capital Expenditures	-7.55B
Free Cash Flow	11.47B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin	84.65%
Operating Margin	48.43%
Pretax Margin	43.65%
Profit Margin	34.51%
EBITDA Margin	51.23%
EBIT Margin	48.43%
FCF Margin	26.10%

Dividends & Yields

This stock pays an annual dividend of 1.66, which amounts to a dividend yield of 2.48%.

Dividend Per Share	1.66
Dividend Yield	2.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	48.61%
Buyback Yield	0.61%
Shareholder Yield	3.09%
Earnings Yield	5.19%
FCF Yield	3.93%

Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 7.88.

Altman Z-Score	7.88
Piotroski F-Score	n/a